A Non-interventional, Multi-centre Study to Investigate the Change in Patient-reported Outcomes in Moderate to Severe COPD Patients Newly Initiated on TRIXEO AEROSPHERE (Budesonide/Glycopyrronium/Formoterol) in Real-life Setting in Romania
Latest Information Update: 12 Jun 2025
At a glance
- Drugs Budesonide/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms COnCORD
- Sponsors AstraZeneca
Most Recent Events
- 05 Jun 2025 Status changed from recruiting to active, no longer recruiting.
- 29 May 2024 Status changed from not yet recruiting to recruiting.
- 18 Apr 2024 New trial record